Archive


Category: A-Alpha Bio

  • Startup A-Alpha Bio sets out to solve a major protein problem facing big pharma

    A-Alpha Bio’s technology analyzes millions of protein-protein interactions simultaneously, a capability that speeds up drug discovery research. Biotech industry partners are already using the technology and now with $20 million in Series A funding, the startup plans to build machine-learning capabilities to crunch the data produced by all of those protein interactions.